生殖医学杂志

参考文献

[1] Li R,Zhang Q,Yang D,et al.Prevalence of polycystic ovary syndrome in women in China:a large community-based study[J].Hum Reprod,2013,28:2562-2569.

[2] 宋颖，李蓉.多囊卵巢综合征中国诊疗指南解读[J].实用妇产科杂志，2018,34:737-741.

[3] 谢幸，孔北华，段涛.妇产科学[M].第9版.北京：人民卫生出版社，2018:348-351.

[4] 多囊卵巢综合征诊治路径专家共识编写组.多囊卵巢综合征诊治路径专家共识[J].中华生殖与避孕杂志，2023,43:337-345.

[5] 中华医学会妇产科学分会内分泌学组及指南专家组.多囊卵巢综合征中国诊疗指南[J].中华妇产科杂志，2018,53:2-6.

[6] Huang ZJ,Zeng Y,Lan P,et al.Advances in structural modifications and biological activities of berberine:an active compound in traditional Chinese medicine[J].Mini Rev Med Chem,2011,11:1122-1129.

[7] 胡金华，胡婷婷，王静华，等.盐酸小檗碱联合二甲双胍对2型糖尿病合并NAFLD患者体脂成分和肝脏脂肪含量的影响[J].浙江医学，2021,43:2327-2331.

[8] 中华医学会内分泌学分会，中华中医药学会糖尿病分会，中国医师协会外科医师分会，等.基于临床的肥胖症多学科诊疗共识(2021年版)[J].中华消化外科杂志，2021,20:1137-1152.

[9] 罗蓉，王宇，缪阿风，等.正常体质量指数的多囊卵巢综合征患者胰岛素抵抗的影响因素分析[J].中国全科医学，2023,26:2012-2017.

[10] 陈诚，张秋菊，钱卫平.多囊卵巢综合征中胰岛素抵抗的诊断与治疗方法[J].生殖医学杂志，2021,30:1664-1669.

[11] 中国医师协会生殖医学专业委员会，中国女医师协会生殖医学专业委员会.反复种植失败临床诊治中国专家共识[J].中华医学杂志，2023,103:89-100.

[12] Schulte MM,Tsai JH,Moley KH.Obesity and PCOS:the effect of metabolic derangements on endometrial receptivity at the time of implantation[J].Reprod Sci,2015,22:6-14.

[13] Moragianni VA,Jones SL,Ryley DA.The effect of body mass index on the outcomes of first assisted reproductive technology cycles[J].Fertil Steril,2012,98:102-108.

[14] Haas CL,Varbo A,Laursen PN,et al.Association between body mass index,weight loss and the chance of pregnancy in women with polycystic ovary syndrome and overweight or obesity:a retrospective cohort study in the UK[J].Hum Reprod,2023,38:471-481.

[15] 韩倩楠，刘瑞连，田学其，等.小檗碱治疗2型糖尿病效果及安全性的meta分析[J].中国医药科学，2022,12:32-36.

[16] 周瑾.糖尿病高脂血症应用盐酸小檗碱联合二甲双胍治疗探析[J].心血管病防治知识(学术版),2014,24:68-69.

[17] 王敏仪，陈姗，张帝开.黄连素与二甲双胍治疗多囊卵巢综合征的随机对照试验系统评价[J].广东医学，2015,36:3866-3870.

[18] 安媛，张雅娟，吕荟明，等.小檗碱对行体外受精-胚胎移植的多囊卵巢综合征患者临床、内分泌、代谢指标及妊娠结局的影响[J].现代中西医结合杂志，2016,25:459-462.

[19] 马玉琨，杨军光，隋明，等.小檗碱治疗多囊卵巢综合征合并胰岛素抵抗疗效研究[J].中国实用妇科与产科杂志，2011,27:684-687.

[20] 马晓蕾，王璐璐，蒋建东.小檗碱对肥胖及其并发症的影响[J].中国医药生物技术，2020,15:301-304.

[21] 常惠，朱梦一，付新，等.小檗碱对多囊卵巢综合征作用机制的研究进展[J].中国中西医结合杂志，2021,41:764-768.

[22] Shen N,Huan Y,Shen Z.Berberine inhibits mouse insulin gene promoter through activation of AMP activated protein kinase and may exert beneficial effect on pancreatic β-cell[J].Eur J Pharmacol,2012,694:120-126.

[23] 周丽斌，陈名道，王晓，等.小檗碱对脂肪细胞分化的影响[J].中华医学杂志，2003,83:338-340.

[24] Brusq JM,Ancellin N,Grondin P,et al.Inhibition of lipid synthesis through activation of AMP kinase:an additional mechanism for the hypolipidemic effects of berberine[J].J Lipid Res,2006,47:1281-1288.

[25] Chang XX,Yan HM,Xu Q,et al.The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet[J].Lipids Health Dis,2012,11:86.

[26] 李慕白，王婷婷，张多加，等.小檗碱改善多囊卵巢综合征伴胰岛素抵抗大鼠子宫组织局部胰岛素抵抗的作用机制研究[J].现代中西医结合杂志，2022,31:153-160.

[27] 高惠民，张婷婷，刘瑞霞，等.肠道菌群和胆汁酸的相互作用与多囊卵巢综合征[J].生殖医学杂志，2022,31:1617-1621.

[28] Vrieze A,Van Nood E,Holleman F,et al.Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome[J].Gastroenterology,2012,143:913-916.

[29] Lindheim L,Bashir M,Münzker J,et al.Alterations in gut microbiome composition and barrier function are associated with reproductive and metabolic defects in women with polycystic ovary syndrome(PCOS):a pilot study[J/OL].PLoS One,2017,12:e0168390.

[30] Liu D,Zhang Y,Liu Y,et al.Berberine modulates gut microbiota and reduces insulin resistance via the TLR4 signaling pathway[J].Exp Clin Endocrinol Diabetes,2018,126:513-520.

[31] Shen HR,Xu X,Ye D,et al.Berberine improves the symptoms of DHEA-induced PCOS rats by regulating gut microbiotas and metabolites[J].Gynecol Obstet Invest,2021,86:388-397.

[32] Kuang H,Duan Y,Li D,et al.The role of serum inflammatory cytokines and berberine in the insulin signaling pathway among women with polycystic ovary syndrome[J/OL].PLoS One,2020,15:e0235404.

[33] Lasselin J,Capuron L.Chronic low-grade inflammation in metabolic disorders:relevance for behavioral symptoms[J].Neuroimmunomodulation,2014,21:95-101.

[34] Charrière G,Cousin B,Arnaud E,et al.Preadipocyte conversion to macrophage.Evidence of plasticity[J].J Biol Chem,2003,278:9850-9855.

[35] Zhu Q,Scherer PE.Immunologic and endocrine functions of adipose tissue:implications for kidney disease[J].Nat Rev Nephrol,2018,14:105-120.

[36] Liu S,Yin C,Ding M,et al.Berberine inhibits tumor necrosis factor-α-induced expression of inflammatory molecules and activation of nuclear factor-κB via the activation of AMPK in vascular endothelial cells[J].Mol Med Rep,2015,12:5580-5586.